Mycoses in HIV-infected patients in the era of highly active antiretroviral therapy;Las micosis en los pacientes infectados por el VIH en la era de los tratamientos antirretrovirales de gran eficacia

Revista Iberoamericana de Micologia

Volumn 19, Issue 1, 2002, Pages 5-8

  Santamaría Jáuregui, Juan Miguel ^a   Zubero Sulibarria, Zuriñe ^a  

^a HOSPITAL DE BASURTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIRETROVIRUS AGENT; CLOTRIMAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MYCOSIS; PENICILLIUM MARNEFFEI; PROGNOSIS; SHORT SURVEY; SPOROTHRIX SCHENCKII;

EID: 0036249428     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (31)

1. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
2. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis
3. Inflamatory reactions in HIV-1-Infected persons after initiation of highly active antiretroviral therapy
4. Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections
5. Tropical infectious diseases in human inmunodeficiency virus infected patients
6. Oropharyngeal candidiasis in patients with human inmunodeficiency virus: Correlation of clinical outcome with in vitro resistance, serum azole levels, and inmunosuppression
7. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associatted with trends toward reduced rates of carriage of fluconazol-resistant C. albicans in humman inmunodeficiency virus-infected patients
8. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy
9. Itraconazole versus ketoconazole in the treatment of oral and esophageal candidiasis in patients infected with HIV
10. Ramdomized trial of itraconazole oral solution for oropharyngeal candidiasis in Aids
11. Comparative in vitro activity of voriconazole and itraconazol against fluconazolsusceptible and fluconazol-resistant clinical isolates of Candida species from Spain
12. Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antiretroviral de gran actividad
13. Cryptococcal disease in patients with the acquired inmunodeficiency syndrome: Diagnostic features and outcome and treatment
14. HIV combination therapy: Partial immune reconstitution unmasking latent cryptococcal infection
15. Mediastinal lymphadenitis due to cryptococcal infection in HIV positive patients on hihgly active antiretroviral therapy
16. Paradoxical reactions to Cryptococcus in AIDS patients with immune reconstitution
17. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in the patients with AIDS
18. Liposomal amphotericin B (Ambisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS associated meningitis
19. Diagnosis and management of increased intracraneal pressure in patients with aids and cryptococcal meningitis
20. Susceptibilities o serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphoteriicin B and fluconazol
21. A controlled trial of fluconazol or amphotericin B to prevent the relapse of cryptococcal meningitis in patients with the aqcquired inmunodeficiency syndrome
22. Discontinuation of antifungal therapy for cryptococcosis after inmunologic response to antiretroviral therapy
23. Discontinuation of secondary prophylasis for criptococcal meningitis in HIV-infected patients responding to highly-active antiretroviral therapy
24. 3. Demonstration of efficacy in a positive multicenter trial
25. Pulmonary aspergillosis and invasive disease in AIDS. Review of 342 cases
26. Central nervous system aspergillosis in patients with human inmunodeficiency virus infection
27. Endemic mycoses: A treatment update
28. Clinical presentation and risk behaviours of patients with the acquired inmunodeficiency syndrome in Thailand, 1994-1998: Regional variation and temporal trends
29. Itraconazol maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial